The Clorox Company (NYSE:CLX) Shares Sold by Wells Fargo & Company MN

Wells Fargo & Company MN decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 12.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 482,215 shares of the company's stock after selling 65,570 shares during the quarter. Wells Fargo & Company MN owned 0.39% of Clorox worth $78,317,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Brooklyn Investment Group increased its stake in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares in the last quarter. Continuum Advisory LLC increased its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares during the period. Millstone Evans Group LLC purchased a new position in Clorox during the 4th quarter worth $31,000. Asset Planning Inc purchased a new position in Clorox during the 4th quarter valued at about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in shares of Clorox in the 4th quarter worth $36,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of research analyst reports. Wells Fargo & Company decreased their price target on Clorox from $161.00 to $155.00 and set an "equal weight" rating for the company in a research note on Wednesday, April 2nd. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. DA Davidson dropped their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Barclays reduced their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research report on Friday. Finally, Evercore ISI raised their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Clorox has an average rating of "Hold" and a consensus price target of $156.75.

Clorox Trading Down 0.4 %

CLX stock traded down $0.59 during midday trading on Monday, hitting $140.85. The stock had a trading volume of 303,316 shares, compared to its average volume of 1,294,385. The company's 50-day moving average price is $147.39 and its 200 day moving average price is $157.21. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market cap of $17.35 billion, a PE ratio of 38.48, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the firm earned $2.16 earnings per share. On average, equities research analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.46%. Clorox's payout ratio is currently 133.33%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.